Royal Unibrew 1Q26 Preview: Near-Term Strength Masks Emerging Full-Year Cost Headwinds

Core Conclusion

We expect Royal Unibrew (RBREW.CO) to report a strong 1Q26, with organic EBIT growth of +19%, significantly above its full-year target of 6-10%. However, this strength is driven by temporary factors—Easter timing and an easy comparison from last year's Finnish strikes—and masks a more challenging cost outlook for FY26 due to the Middle East conflict. The earnings normalization and re-rating story is largely reflected in the stock, which now trades at a -5% P/E discount to European Staples versus -12% in October 2025. With risk-reward balanced, we maintain our Equal-weight rating and DKK 595 price target.

What the Market Might Be Missing

The market may be underestimating the magnitude of cost headwinds stemming from the Middle East conflict for the remainder of FY26. While the robust 1Q26 print (+19% organic EBIT growth) will garner attention, the emerging cost pressure from 2Q26 onward poses an above-consensus challenge to RBREW's pricing and cost discipline needed to hit its full-year organic EBIT growth target. The current valuation discount may not fully price in this more severe cost environment.

Evidence Chain

1Q26 strength is cyclical, not structural. We forecast 1Q26 organic EBIT growth of +19%, consensus +19%, driven by non-recurring factors. Volume growth of +5.5% is boosted by the 2026 Easter falling in 1Q (vs. 2Q in 2025) and lapping the severe sector-wide strikes in Finland, which caused an 8% volume decline in Northern Europe in 1Q25. The investment implication is that this outperformance versus the full-year guide is unsustainable and should not be extrapolated.

Exiting low-margin snacks immediately improves profitability. The divestment of the snacks business, effective 1Q26, will reduce 2026 group revenue by approximately 3.5% but provides a clear tailwind to EBIT margin. This move is a key driver behind our forecast for a 105bps y/y EBIT margin expansion in 1Q26. The action underscores management's focus on portfolio quality over sheer scale.

The Middle East conflict introduces material cost uncertainty. Management's prior outlook for "modest" input cost inflation has become more challenging. While hedging and fixed supplier agreements provide partial coverage for 2026, the conflict's impact on costs is expected to become more pronounced from 2Q26. This elevates the execution risk for RBREW's full-year targets, necessitating greater pricing power and cost control than previously anticipated.

Valuation discount to peers appears justified given the risk profile. RBREW trades at 15.5x 2026E P/E, a ~5% discount to the European Staples sector at 16.3x. However, its expected 2025-28E EPS CAGR of +9.4% is superior to the sector's +7.1%. The investment takeaway is that the narrowed discount (from -12% in Oct-2025) and the emerging cost headwinds support a balanced view, negating a clear re-rating catalyst.

Key Disagreements & Risks

• Input cost inflation from the Middle East conflict exceeding expectations and eroding margins.
• Intensified competition limiting the company's ability to pass on higher costs, impacting pricing and mix.
• Weaker consumer trends leading to volume growth below forecasts.
• Adverse regulatory changes (e.g., targeting sugar or artificial ingredients) affecting demand or cost structure.

Valuation & Trade Implications

Our DKK 595 price target, offering ~13% upside from current levels, is derived from a blend of DCF and relative P/E methodologies. We maintain an Equal-weight rating. The risk-reward is balanced as the earnings normalization story is now reflected in consensus, and the valuation discount has materially narrowed. While the strong 1Q26 result may provide a near-term trading opportunity, the looming cost pressures for the rest of the year cap the upside potential.

Appendix: Key Financial Forecasts